MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 555271 | Name: LM22B-10
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

LM22B-10 is a TrkB and TrkC agonist. LM22B-10 exhibits neurotrophic activity (EC50 = 200-300 nM). LM22B-10 improves survival and increases neurite outgrowth in hippocampal cells in vitro. LM22B-10 increased cell survival and strongly accelerated neurite outgrowth, superseding the effects of brain-derived neurotrophic factor (BDNF), NT-3 or the two combined.

Chemical Structure

LM22B-10
LM22B-10
CAS#342777-54-2

Theoretical Analysis

MedKoo Cat#: 555271

Name: LM22B-10

CAS#: 342777-54-2

Chemical Formula: C27H33ClN2O4

Exact Mass: 484.2129

Molecular Weight: 485.02

Elemental Analysis: C, 66.86; H, 6.86; Cl, 7.31; N, 5.78; O, 13.19

Price and Availability

Size Price Availability Quantity
50mg USD 450.00 2 Weeks
100mg USD 850.00 2 Weeks
200mg USD 1,450.00 2 Weeks
500mg USD 2,250.00 2 Weeks
1g USD 3,450.00 2 Weeks
2g USD 5,650.00 2 Weeks
5g USD 7,850.00 2 Weeks
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
LM22B-10; LM22B 10; LM22B10; LM 22B10; LM-22B10; LM22B10;
IUPAC/Chemical Name
2,2',2',2'''-[[(4-Chlorophenyl)methylene]bis(4,1-phenylenenitrilo)]tetrakisethanol
InChi Key
QCXQLSGBOUUVNH-UHFFFAOYSA-N
InChi Code
InChI=1S/C27H33ClN2O4/c28-24-7-1-21(2-8-24)27(22-3-9-25(10-4-22)29(13-17-31)14-18-32)23-5-11-26(12-6-23)30(15-19-33)16-20-34/h1-12,27,31-34H,13-20H2
SMILES Code
ClC1=CC=C(C(C2=CC=C(N(CCO)CCO)C=C2)C3=CC=C(N(CCO)CCO)C=C3)C=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Product Data
Instruction
View handling instruction
Biological target:
LM22B-10 is an activator of TrkB/TrkC neurotrophin receptor, and can induce TrkB, TrkC, AKT and ERK activation in vitro and in vivo.
In vitro activity:
The cells were treated with LM22B-10 (an ERK activator) or transfected with the constitutive activation of the mitogen-activated protein kinase 1 (CaMEK) gene. Administering LM22B-10 or transfecting the CaMEK gene significantly activated the phosphorylation levels of ERK1/2 protein and reduced the proportion of cardiomyocyte apoptosis (P<0.05). Reference: Ann Transl Med. 2022 Nov;10(22):1238. https://pubmed.ncbi.nlm.nih.gov/36544682/
In vivo activity:
In vivo model of PNI (perineural invasion) was established via inoculating PANC-1 cells into mice. PANC-1 cells and mice were also treated with LM22B-10 (an activator of TrkC) to confirm the mechanisms involving NT-3/TrkC in PNI of PC both in vivo and in vitro. LM22B-10 partially abolished the effects of MMP1 knockdown both in vivo and in vitro. Reference: J Clin Lab Anal. 2022 Nov;36(11):e24719. https://pubmed.ncbi.nlm.nih.gov/36181286/
Solvent mg/mL mM
Solubility
DMSO 81.4 167.78
Ethanol 44.0 90.61
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 485.02 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Yu F, Liu F, Luo JY, Zhao Q, Wang HL, Fang BB, Li XM, Yang YN. Targeted activation of ERK1/2 reduces ischemia and reperfusion injury in hyperglycemic myocardium by improving mitochondrial function. Ann Transl Med. 2022 Nov;10(22):1238. doi: 10.21037/atm-22-5149. PMID: 36544682; PMCID: PMC9761117. 2. Yang Y, Wu Y, Hou L, Ge X, Song G, Jin H. Heat shock protein 20 suppresses breast carcinogenesis by inhibiting the MAPK and AKT signaling pathways. Oncol Lett. 2022 Nov 3;24(6):462. doi: 10.3892/ol.2022.13582. PMID: 36380873; PMCID: PMC9650602. 3. Xu X, Lu X, Chen L, Peng K, Ji F. Downregulation of MMP1 functions in preventing perineural invasion of pancreatic cancer through blocking the NT-3/TrkC signaling pathway. J Clin Lab Anal. 2022 Nov;36(11):e24719. doi: 10.1002/jcla.24719. Epub 2022 Sep 30. PMID: 36181286; PMCID: PMC9701873. 4. Wang D, Li Y, Dai L, Wang Y, Zhao C, Wang W, Zhang Y, Zhao Y, Yu T. 1,2,3,4,6‑penta‑O‑galloyl‑β‑D‑glucose alleviates inflammation and oxidative stress in diabetic nephropathy rats through MAPK/NF‑κB and ERK/Nrf2/HO‑1 signaling pathways. Exp Ther Med. 2022 Aug 26;24(4):639. doi: 10.3892/etm.2022.11576. PMID: 36160883; PMCID: PMC9468796.
In vitro protocol:
1. Yu F, Liu F, Luo JY, Zhao Q, Wang HL, Fang BB, Li XM, Yang YN. Targeted activation of ERK1/2 reduces ischemia and reperfusion injury in hyperglycemic myocardium by improving mitochondrial function. Ann Transl Med. 2022 Nov;10(22):1238. doi: 10.21037/atm-22-5149. PMID: 36544682; PMCID: PMC9761117. 2. Yang Y, Wu Y, Hou L, Ge X, Song G, Jin H. Heat shock protein 20 suppresses breast carcinogenesis by inhibiting the MAPK and AKT signaling pathways. Oncol Lett. 2022 Nov 3;24(6):462. doi: 10.3892/ol.2022.13582. PMID: 36380873; PMCID: PMC9650602.
In vivo protocol:
1. Xu X, Lu X, Chen L, Peng K, Ji F. Downregulation of MMP1 functions in preventing perineural invasion of pancreatic cancer through blocking the NT-3/TrkC signaling pathway. J Clin Lab Anal. 2022 Nov;36(11):e24719. doi: 10.1002/jcla.24719. Epub 2022 Sep 30. PMID: 36181286; PMCID: PMC9701873. 2. Wang D, Li Y, Dai L, Wang Y, Zhao C, Wang W, Zhang Y, Zhao Y, Yu T. 1,2,3,4,6‑penta‑O‑galloyl‑β‑D‑glucose alleviates inflammation and oxidative stress in diabetic nephropathy rats through MAPK/NF‑κB and ERK/Nrf2/HO‑1 signaling pathways. Exp Ther Med. 2022 Aug 26;24(4):639. doi: 10.3892/etm.2022.11576. PMID: 36160883; PMCID: PMC9468796.
1: Zhang T, Liao JY, Yu L, Liu GS. Regulating effect of glycyrrhetinic acid on bronchial asthma smooth muscle proliferation and apoptosis as well as inflammatory factor expression through ERK1/2 signaling pathway. Asian Pac J Trop Med. 2017 Dec;10(12):1172-1176. doi: 10.1016/j.apjtm.2017.10.025. Epub 2017 Oct 28. PubMed PMID: 29268974. 2: Yang T, Massa SM, Tran KC, Simmons DA, Rajadas J, Zeng AY, Jang T, Carsanaro S, Longo FM. A small molecule TrkB/TrkC neurotrophin receptor co-activator with distinctive effects on neuronal survival and process outgrowth. Neuropharmacology. 2016 Nov;110(Pt A):343-361. doi: 10.1016/j.neuropharm.2016.06.015. Epub 2016 Jun 19. PubMed PMID: 27334657.